Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $159,313.80. Following the completion of the sale, the chief executive officer now directly owns 418,637 shares in the company, valued at approximately $1,423,365.80. The trade was a 10.07 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Amit Gupta also recently made the following trade(s):
- On Friday, January 24th, Amit Gupta sold 15,160 shares of Cardlytics stock. The shares were sold at an average price of $3.92, for a total value of $59,427.20.
- On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total value of $21,887.88.
Cardlytics Stock Performance
Cardlytics stock traded down $0.25 during midday trading on Wednesday, hitting $3.12. 795,583 shares of the company’s stock were exchanged, compared to its average volume of 892,856. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. The stock has a market cap of $158.56 million, a price-to-earnings ratio of -0.51 and a beta of 1.54. Cardlytics, Inc. has a 12-month low of $2.76 and a 12-month high of $20.52. The firm’s 50 day simple moving average is $3.47 and its 200 day simple moving average is $3.73.
Hedge Funds Weigh In On Cardlytics
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on CDLX. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research note on Friday, January 17th. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Cardlytics has a consensus rating of “Hold” and an average target price of $6.92.
Get Our Latest Research Report on Cardlytics
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Read More
- Five stocks we like better than Cardlytics
- The 3 Best Fintech Stocks to Buy Now
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is a Secondary Public Offering? What Investors Need to Know
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Trading Halts Explained
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.